The Life Sciences Tools and Services Industry in the Health Care Sector includes companies involved in drug discovery, development, and production continuum by providing analytical tools, instruments, consumables and supplies, clinical trial services, and contract research services (including firms primarily servicing the pharmaceutical and biotechnology industries).
|Last % Change||Market Cap||Sector|
|P/E (Last Year GAAP Actual)||37.63|
|P/E (This Year's Estimate)||30.66|
|EPS Growth (TTM vs. Prior TTM)||101.11%|
|Revenue Growth (TTM vs. Prior TTM)||10.13%|
|Return on Equity (TTM)||18.29%|
|Return on Investment (TTM)||9.89%|
|Total Debt/Equity (TTM)||80.23|
|How are performance, market cap, market weight, and fundamentals calculated?|
News, commentary, market data and research reports are from third-party sources unaffiliated with Fidelity, unless otherwise noted, and are provided for informational purposes only. Fidelity does not endorse or adopt third party content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.
Past performance is no guarantee of future results.